3sbio

3sbio, a Pharmaceutical Preparation Manufacturing company headquartered in China, reported its 2024 emissions. For 2024, the company's Scope 1 emissions were approximately 13,304,070 kg CO2e, and its Scope 2 market-based emissions were approximately 55,832,050 kg CO2e, resulting in combined Scope 1 and 2 market-based emissions of about 69,136,120 kg CO2e. In 2023, 3sbio's Scope 1 emissions were about 11,663,450 kg CO2e, and its Scope 2 location-based emissions were around 48,986,080 kg CO2e, with combined Scope 1 and 2 location-based emissions totalling approximately 60,649,530 kg CO2e. The company has not disclosed Scope 3 emissions for these years.

Looking back, in 2022, 3sbio's Scope 1 emissions were approximately 7,257,230 kg CO2e, and Scope 2 location-based emissions were about 38,639,330 kg CO2e, leading to combined Scope 1 and 2 location-based emissions of around 45,896,560 kg CO2e. In 2021, the company's Scope 1 emissions were roughly 6,587,770 kg CO2e, and Scope 2 emissions were about 49,624,790 kg CO2e, making the total Scope 1 and 2 emissions around 56,212,570 kg CO2e. For 2020, Scope 1 emissions were approximately 6,516,090 kg CO2e, and Scope 2 emissions were about 41,204,790 kg CO2e, for a total of approximately 47,720,880 kg CO2e for Scope 1 and 2. In 2019, 3sbio reported Scope 1 emissions of approximately 5,960,680 kg CO2e and Scope 2 emissions of about 42,724,590 kg CO2e, with a total of approximately 48,685,270 kg CO2e for Scope 1 and 2.

3sbio has disclosed Scope 1 and Scope 2 emissions but has consistently noted that data for Scope 3 categories, such as purchased goods and services, is missing for the reported years. No specific climate commitments or reduction targets, including Science Based Targets (SBTi), have been reported.